VC firm announces first close of women’s health fund

The venture capital firm KIDRON Capital Assets has announced the successful first close of its fund dedicated to women’s health.

Led by two female general partners with investment and industry expertise in the health tech sector, KIDRON aims to generate returns for its investors by capitalising on the extensive, yet often overlooked, opportunities within women’s health.

The firm seeks to support health tech companies that “leverage” patients data analytics to enable predictive, preventive and precision healthcare with emphasis on the most pressing unmet medical needs in women’s health.

“We are pleased to announce the first close of Kidron Capital, the first women’s health-focused VC fund with a presence in Israel,” Maria Gajda Horowitz, founder and managing partner at Kidron Capital Assets, said in a LinkedIn post.

“The fund will invest in early-stage companies that focus on improving the lives of women across the spectrum of conditions, from those unique to women to those that are predominant or different in women.”

The investment reach, according to Horowitz, extends across Europe, the US and Israel, covering sectors, such as medical devices, diagnostics, digital health, therapeutics and services.

KIDRON has already made inaugural investments in several US-based companies, including Beyond Medicine, a start-up working towards improving skin rejuvenation and alleviating menopausal symptoms, Portal, a solution for oncology clinics and Renal Guard, a system designed to prevent acute kidney injury (AKI).